Showing results (1381-1390 of 6,769) with videos related to

Sort By:
Pageof 677
Clinical Therapeutics|November 19, 2013
Comparison of the efficacy of Lamivudine plus adefovir versus entecavir in the treatment of Lamivudine-resistant chronic hepatitis B: a systematic review and meta-analysisZe-Bing Huang, Shu-Shan Zhao, Yan Huang, et al.
Clinical Therapeutics|November 19, 2013
Evaluation of the effect of Naloxegol on cardiac repolarization: a randomized, placebo- and positive-controlled crossover thorough QT/QTc study in healthy volunteersChrister Gottfridsson, Glenn Carlson, Jaakko Lappalainen, et al.
Clinical Therapeutics|October 26, 2013
Systematic review of tumor necrosis factor inhibitor discontinuation studies in rheumatoid arthritisIris Navarro-Millán, Sebastian E Sattui, Jeffrey R Curtis
Clinical Therapeutics|January 27, 2018
How Sensors, Devices, and Biomarkers Can Transform Precision Medicine: Perspectives From a Clinical and Translational Science InstituteJill L Maron, Graham B Jones
Clinical Therapeutics|January 27, 2018
Gender Differences in Pain Experience and Treatment after Motor Vehicle Collisions: A Secondary Analysis of the CRASH Injury StudyTracy E Madsen, Samuel McLean, Wanting Zhai, et al.
Clinical Therapeutics|January 27, 2018
Perception and Practice Among Emergency Medicine Health Care Providers Regarding Discharging Patients After Opioid AdministrationRyan M Surmaitis, Alexandra Amaducci, Kathryn Henry, et al.
Clinical Therapeutics|February 7, 2018
A Phase III, Multicenter, Randomized, Double-blind, Active Comparator Clinical Trial to Compare the Efficacy and Safety of Combination Therapy With Ezetimibe and Rosuvastatin Versus Rosuvastatin Monotherapy in Patients With Hypercholesterolemia: I-ROSETTE (Ildong Rosuvastatin & Ezetimibe for Hypercholesterolemia) Randomized Controlled TrialSoon Jun Hong, Han Saem Jeong, Jeong Cheon Ahn, et al.
Clinical Therapeutics|November 28, 2017
Cost-effectiveness of Paclitaxel + Ramucirumab Combination Therapy for Advanced Gastric Cancer Progressing After First-line Chemotherapy in JapanShota Saito, Yusuke Muneoka, Takashi Ishikawa, et al.
Clinical Therapeutics|December 31, 2017
Phase 1b Study of the Safety, Pharmacokinetics, and Disease-related Outcomes of the Matrix Metalloproteinase-9 Inhibitor Andecaliximab in Patients With Rheumatoid ArthritisDavid L Gossage, Blanka Cieslarová, Sophe Ap, et al.
Clinical Therapeutics|January 14, 2018
Women and the Experience of Pain and Opioid Use Disorder: A Literature-based CommentaryAndrew L Koons, Marna Rayl Greenberg, Robert D Cannon, et al.
Pageof 677